SVT-40776 in Patients Suffering From Overactive Bladder Syndrome

Status Completed

Clinical Trial Summary

The study will examine which dose of SVT-40776 is best in terms of efficacy, safety and tolerability compared to placebo and tolterodine

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00507169
Study type	Interventional
Source	Salvat
Contact
Status	Completed
Phase	Phase 2
Start date	September 2006
Completion date	September 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02216214` - Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)	Phase 4
Completed	`NCT02294396` - Postmarketing Study to Evaluate add-on Therapy With Anticholinergics in Patients With Overactive Bladder (OAB) on Mirabegron.	Phase 4
Completed	`NCT01936870` - Drug Use Investigation for Toviaz
Completed	`NCT03846895` - Vaginal CO2 Laser in Postmenopausal Women With Overactive Bladder Syndrome (OAB)	N/A
Completed	`NCT03903094` - A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden
Terminated	`NCT04451382` - PTNS vs Botox of Refractory OAB
Terminated	`NCT04641975` - A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB)	Phase 3
Completed	`NCT00366002` - Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder	Phase 4
Completed	`NCT02138747` - A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)	Phase 4
Completed	`NCT03602508` - Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
Completed	`NCT03572231` - A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
Completed	`NCT05211193` - Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).
Completed	`NCT04562090` - A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder	Phase 4
Completed	`NCT00282932` - Detrol LA In Men With Overactive Bladder.	Phase 4
Completed	`NCT01639794` - Vesitirim™ in Men Postmarketing Observational Study	N/A
Completed	`NCT00742833` - A Phase II Study of KUC-7483 in Patients With Overactive Bladder	Phase 2
Withdrawn	`NCT01317810` - A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication	N/A